expert roundtables

Interpreting Chronic Lymphocytic Leukemia Prognostic Markers in the Novel Treatment Era
Oncology

Interpreting Chronic Lymphocytic Leukemia Prognostic Markers in the Novel Treatment Era

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Rheumatology

Use of Rheumatoid Arthritis Biomarkers to Stratify Patients

expert roundtables
By Alan L. Epstein, MD; Vibeke Strand, MD, MACR, FACP
Clinical Considerations in Managing Women With Rheumatoid Arthritis Before, During, and After Pregnancy
Rheumatology

Clinical Considerations in Managing Women With Rheumatoid Arthritis Before, During, and After Pregnancy

expert roundtables
By Alan L. Epstein, MD; Vibeke Strand, MD, MACR, FACP
Strategies for Managing Patients With Rheumatoid Arthritis and Previous or Comorbid Cancer
Rheumatology

Strategies for Managing Patients With Rheumatoid Arthritis and Previous or Comorbid Cancer

expert roundtables
By Alan L. Epstein, MD; Vibeke Strand, MD, MACR, FACP
Management Strategies for Patients With Difficult-to-Treat Rheumatoid Arthritis
Rheumatology

Management Strategies for Patients With Difficult-to-Treat Rheumatoid Arthritis

expert roundtables
By Alvin F. Wells, MD, PhD; Jonathan S. Hausmann, MD
Load More